Impact Therapeutics News and Activities

Acquisition, funding and merger involving Impact Therapeutics.

• Impact Therapeutics has just announced a $55 Million fundraising (posted on August 8 2025).

View the org chart displaying its 6 main executives

Most searched biographies at Impact Therapeutics

• Sui Xiong Cai, Chief Executive Officer
• Cong Xu, Chairman of the Board
• Susie Xu, Executive Vice President & Chief Financial Officer

Create your alert
to follow the executive moves at Impact Therapeutics.

Impact Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Impact Therapeutics

Social media about Impact Therapeutics

• Impact Therapeutics on Wikipedia, Google News & Yahoo Finance
• Impact Therapeutics on LinkedIn, X (Twitter) & YouTube